No Widgets found in the Sidebar

Biosimilar Shows Comparable Safety, Efficacy to Reference Product in Patients With RA

  ​... produced significantly lower injection site reactions and injection site erythema compared with etanercept in patients with rheumatoid arthritis.  ... produced significantly lower injection site reactions and injection site…

Read More

China NMPA Approves Bio-Thera Solutions’ BAT1806, A Biosimilar to Actemra® (Tocilizumab)

  ​... and has been approved for the treatment of rheumatoid arthritis (RA), systemic juvenile idiopathic arthritis (sJIA), and cytokine release ...  ... and has been approved for the treatment of…

Read More

Etanercept biosimilar demonstrates long-term safety, efficacy in rheumatoid arthritis

  ​YLB113, a biosimilar of the reference product etanercept, appears to be safe for long-term treatment of patients with rheumatoid arthritis, ...  YLB113, a biosimilar of the reference product etanercept, appears…

Read More

Patients with Rheumatoid Arthritis Satisfied with Switch to Adalimumab Biosimilar – HCPLive

  ​... mirror findings from other large-scale studies evaluating the safety and efficacy of biosimilars in patients with rheumatoid arthritis.  ... mirror findings from other large-scale studies evaluating the safety…

Read More

Samsung Bioepis speeding up US launch of Humira biosimilar – The Korea Herald

  ​Hadlima is Samsung Bioepis' biosimilar referencing AbbVie's blockbuster drug Humira, used to treat rheumatoid arthritis, Crohn's disease, ...  Hadlima is Samsung Bioepis' biosimilar referencing AbbVie's blockbuster drug Humira, used to…

Read More